Ultragenyx Pharmaceutical shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Ultragenyx Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Ultragenyx Pharmaceutical held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ultragenyx Pharmaceutical by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $165M | 3.4M | 47.82 |
| 2023-09-30 | $113M | 3.2M | 35.65 |
| 2023-06-30 | $167M | 3.6M | 46.13 |
| 2023-03-31 | $142M | 3.5M | 40.10 |
| 2022-12-31 | $190M | 4.1M | 46.33 |
| 2022-03-31 | $863M | 12M | 72.62 |
| 2021-12-31 | $969M | 12M | 84.09 |
| 2021-09-30 | $1.0B | 12M | 90.19 |
| 2021-06-30 | $1.0B | 11M | 95.35 |
| 2021-03-31 | $1.2B | 11M | 113.86 |
| 2020-12-31 | $1.3B | 9.5M | 138.43 |
| 2020-09-30 | $686M | 8.3M | 82.19 |
| 2020-06-30 | $600M | 7.7M | 78.22 |
| 2020-03-31 | $209M | 4.7M | 44.43 |
| 2019-12-31 | $192M | 4.5M | 42.71 |
| 2019-09-30 | $191M | 4.5M | 42.78 |
| 2019-06-30 | $293M | 4.6M | 63.50 |
| 2019-03-31 | $243M | 3.5M | 69.36 |
| 2018-12-31 | $119M | 2.7M | 43.48 |
| 2018-09-30 | $212M | 2.8M | 76.34 |
| 2018-06-30 | $215M | 2.8M | 76.87 |
| 2018-03-31 | $115M | 2.3M | 50.99 |
| 2017-12-31 | $98M | 2.1M | 46.38 |
| 2017-06-30 | $109M | 1.8M | 62.11 |
| 2017-03-31 | $113M | 1.7M | 67.78 |
| 2016-12-31 | $117M | 1.7M | 70.31 |
| 2016-09-30 | $130M | 1.8M | 70.94 |
| 2016-06-30 | $78M | 1.6M | 48.91 |
| 2016-03-31 | $85M | 1.3M | 63.31 |
| 2015-12-31 | $152M | 1.4M | 112.18 |
| 2015-09-30 | $131M | 1.4M | 96.31 |
| 2015-03-31 | $77M | 1.2M | 62.09 |
| 2014-12-31 | $58M | 1.3M | 43.88 |
| 2014-06-30 | $54M | 1.3M | 42.83 |
| 2014-03-31 | $65M | 1.4M | 46.87 |